| Filing Date | Form | Description | Issuer | View |
|---|---|---|---|---|
| 4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
| 8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
| 8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
| DEFA14A |
Additional proxy soliciting materials - definitive |
Intellia Therapeutics, Inc. | ||
| 8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
| 10-Q |
Quarterly report which provides a continuing view of a company's financial position |
Intellia Therapeutics, Inc. | ||
| DEF 14A |
Official notification to shareholders of matters to be brought to a vote ("Proxy") |
Intellia Therapeutics, Inc. | ||
| DEFA14A |
Additional proxy soliciting materials - definitive |
Intellia Therapeutics, Inc. | ||
| PRE 14A |
A preliminary proxy statement providing notification matters to be brought to a vote |
Intellia Therapeutics, Inc. | ||
| ARS |
An annual report to security holders |
Intellia Therapeutics, Inc. |
Displaying 91 - 100 of 590 results
Data provided by Kaleidoscope.